Jeffrey R. Balser, MD, PhD
The goals of this discussion are to introduce the statistical challenges inherent to using genomic information to predict drug action, and to describe an approach to deducing genotype-phenotype relationships using large-scale DNA collection coupled to de-identified data from an electronic health record.